<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 67-year-old man with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the colon had recurrent <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The patient's level of serum antithrombin III was found to be below <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> therapy led to further reduction, resulting in failure of adequate anticoagulation </plain></SENT>
<SENT sid="3" pm="."><plain>The patient subsequently died of massive <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> despite <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>We believe the antithrombin III level should be routinely determined for patients receiving <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
</text></document>